Granular Psyllium Laxative Reclassification Unsupported – Madaus
This article was originally published in The Tan Sheet
Executive Summary
FDA's proposed prohibition on the use of bulk-forming laxative psyllium ingredients in granular dosage form is based on "biased, incomplete, confused, and highly selective" information, according to ingredient manufacturer Madaus AG